TransMedics to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024

Rhea-AI Summary

TransMedics Group, Inc. (TMDX) to release financial results for Q4 and full year 2023, focusing on organ transplant therapy. Conference call scheduled for February 26, 2024.

ANDOVER, Mass., Feb. 12, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the fourth quarter and full year 2023 after market close on Monday, February 26, 2024. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Investors interested in listening to the conference call may do so by dialing (866) 807-9684 for domestic callers or (412) 317-5415 for international callers and ask to be joined into the TransMedics call. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-26-2024-302059630.html

SOURCE TransMedics Group, Inc.

FAQ

When will TransMedics Group, Inc. release financial results for Q4 and full year 2023?

TransMedics Group, Inc. will release financial results for the fourth quarter and full year 2023 after market close on Monday, February 26, 2024.

What medical technology does TransMedics Group, Inc. specialize in?

TransMedics Group, Inc. specializes in transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure.

How can investors listen to the conference call hosted by TransMedics Group, Inc.?

Investors can listen to the conference call hosted by TransMedics Group, Inc. by dialing (866) 807-9684 for domestic callers or (412) 317-5415 for international callers and ask to be joined into the TransMedics call.

Where can investors find the live and archived webcast of the event hosted by TransMedics Group, Inc.?

Investors can find the live and archived webcast of the event hosted by TransMedics Group, Inc. on the 'Investors' section of the TransMedics website at https://investors.transmedics.com/.